Global Orally Disintegrating Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Orally Disintegrating Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Orally Disintegrating Tablets market size was valued at USD 14290 million in 2023 and is forecast to a readjusted size of USD 30040 million by 2030 with a CAGR of 11.2% during review period.

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.

The Global Info Research report includes an overview of the development of the Orally Disintegrating Tablets industry chain, the market status of CNS Diseases (Anti-Psychotics Drug, Anti-Epileptics Drug), Gastrointestinal Diseases (Anti-Psychotics Drug, Anti-Epileptics Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Orally Disintegrating Tablets.

Regionally, the report analyzes the Orally Disintegrating Tablets markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Orally Disintegrating Tablets market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Orally Disintegrating Tablets market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Orally Disintegrating Tablets industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Anti-Psychotics Drug, Anti-Epileptics Drug).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Orally Disintegrating Tablets market.

Regional Analysis: The report involves examining the Orally Disintegrating Tablets market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Orally Disintegrating Tablets market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Orally Disintegrating Tablets:

Company Analysis: Report covers individual Orally Disintegrating Tablets manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Orally Disintegrating Tablets This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (CNS Diseases, Gastrointestinal Diseases).

Technology Analysis: Report covers specific technologies relevant to Orally Disintegrating Tablets. It assesses the current state, advancements, and potential future developments in Orally Disintegrating Tablets areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Orally Disintegrating Tablets market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Orally Disintegrating Tablets market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other

Market segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other

Major players covered
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Orally Disintegrating Tablets product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablets, with price, sales, revenue and global market share of Orally Disintegrating Tablets from 2019 to 2024.

Chapter 3, the Orally Disintegrating Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Orally Disintegrating Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Orally Disintegrating Tablets market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Orally Disintegrating Tablets.

Chapter 14 and 15, to describe Orally Disintegrating Tablets sales channel, distributors, customers, research findings and conclusion.